Timely reconstitution of immune competence affects clinical outcome following autologous stem cell transplantation

Clinical and Experimental Medicine

Volumn 4, Issue 2, 2004, Pages 78-85

  Porrata, L F ^a   Markovic, S N ^a  

^a MAYO CLINIC   (United States)

Author keywords

Absolute lymphocyte count; Autologous stem cell transplantation; Clinical outcome; Kinetics; Natural killer cells

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTINEOPLASTIC ACTIVITY; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BREAST CANCER; CANCER SURVIVAL; CELL COUNT; CHIMERA; ENZYME RECONSTITUTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENCE; LYMPHOCYTE COUNT; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; OVARY CANCER; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE;

GRAFT VS TUMOR EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPETENCE; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 8644291446     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-004-0041-4     Document Type: Review

References (51)

1. Phillip T, Guglielmi C, Hagenbeek A, Somers R, Van der Lelie H, Bron D, Sonneveld P, Gisselbrecht C, Cahn JY, Harrousseau JL et al (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapse of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 333:1540-1545
2. Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF, Casassus P, Maisonneuve H, Facon T, Ifrah N, Payen C, Bataille R (1996) A prospective randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med 335:91-97
3. Lowenberg B, Verdonck LJ, Dekker AW, Willemze R, Zwaan FE, Planque M de, Abels J, Sonneveld P, Van der Lelie J, Goudsmit R et al (1990) Autologous bone marrow transplantation in acute myeloid leukemias in first remission: results of a Dutch prospective study. J Clin Oncol 8:287-294
4. Klingemann HG, Phillips GL (1991) Immunotherapy after bone marrow transplantation. Bone Marrow Transplant 8:73-81
5. Petersen FB, Appelbaum F, Hill R, Fisher LD, Bigelow CL, Sanders JE, Sullivan KM, Bensinger WI, Witherspoon RP, Storb R et al (1990) Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle. J Clin Oncol 8:638-647
6. Appelbaum FR (2001) Hematopoietic cell transplantation as immunotherapy. Nature 411:385-389
7. Barnes DWH, Corp MJ, Loutit JF, Neal FE (1956) Treatment of murine leukemia with x-rays and homologous bone marrow. Preliminary communication. BMJ 2:626-627
8. Porter DL (2001) The graft-versus-tumor potential of allogeneic cell therapy: an update on donor leukocyte infusions and nonmyeloablative allogeneic stem cell transplantation. J Hematother Stem Cell Res 10:465-480
9. _ (2000) Report on state of the art in blood and marrow transplantation: the IBMTR/ABMTR summary slides with guide. IBMTR/ABMTR Newsletter (online) Spring 7:3-10
10. Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, Cividalli G, Varadi G, Kirschbaum M, Ackerstein A, Samuel S, Amar A, Brautbar C, Ben-Tal O, Eldor A, Or R (1998) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematological diseases. Blood 91:756-763
11. Hogan WJ, Storb R (2003) Therapeutic applications of non-myeloablative hematopoietic stem cell transplantation in malignant disease. Immunol Res 28:1-11
12. Michallet M, Bilger K, Garban F, Attal M, Huyn A, Blaise D, Milpied N, Moreau P, Bordigoni P, Kuentz M, Sadoun A, Cahn JY, Socie G, Thomas X, Arnaud P, Raus N, Lheritier V, Pigneux A, Boiron JM (2001) Allogeneic hematopoietic stem-cell transplantation after non-myeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome. J Clin Oncol 19:3340-3349
13. Junglass C, Marr KA (2002) Infectious risk and outcomes after stem cell transplantation: are nonmyeloablative transplants changing the picture? Curr Opin Infect Dis 15:347-353
14. Djulbegovic B, Seidenfeld J, Bonnell C, Kumar A (2003) Nonmyeloablative allogeneic stem-cell transplantation for hematologic malignancies: a systemic review. Cancer Control 10:17-41
15. Powles R, Singhal S, Treleaven J, Kulkarni S, Horton C, Mehta J (1998) Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation. Blood 91:3481-3486
16. Pavletic ZS, Joshi SS, Pirruccello SJ, Tarantolo SR, Kollath J, Reed EC, Bierman PJ, Vose JM, Warkentin PI, Gross TG, Nasrati K, Armitage JO, Kessinger A, Bishop MR (1998) Lymphoid reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies. Bone Marrow Transplant 21:33-41
17. Porrata LF, Gertz MA, Inwards DJ, Litzow MR, Lacy MQ, Tefferi A, Gastineau DA, Dispenzieri A, Ansell SM, Micallef IN, Geyer SM, Markovic SN (2001) Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma. Blood 98:579-585
18. Porrata LF, Litzow MR, Tefferi A, Letendre L, Kumar S, Geyer SM, Markovic SN (2002) Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia. Leukemia 16:1311-1318
19. Porrata LF, Inwards DJ, Micallef IN, Ansell SM, Geyer SM, Markovic SN (2002) Early lymphocyte recovery post-autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkin's disease. Br J Haematol 117:629-633
20. Porrata LF, Ingle JN, Litzow MR, Geyer SM, Markovic SN (2001) Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer. Bone Marrow Transplant 28:865-871
21. Nieto Y, Jones RB, Bearman SI et al (2003) Prognostic analysis of the early lymphocyte recovery in patients (PTS) with advanced breast cancer receiving high dose chemotherapy (HDC) with an autologous hematopoietic progenitor cell transplant (abstract). Biol Blood Marrow Transplant 9:72
22. Oliveira MR, Hyashi M, Magalhaes-Silverman M et al (2002) Early lymphocyte recovery predicts for progression-free survival (PFS) in Hodgkin's lymphoma (HL) patients following autologous stem cell transplant (ASCT) using the same ablative regimen (abstract). Blood 100[Suppl]:2551
23. Gordan LN, Sugrue MW, Lynch JW, Williams KD, Khan SA, Moreb JS (2003) Correlation of early lymphocyte recovery and progressive-free survival after autologous stem-cell transplant in patients with Hodgkin's and non-Hodgkin's lymphoma. Bone Marrow Transplant 31:1009-1013
24. Herr AL, Edwards MD, Lachance S et al (2002) Predictive factors of early lymphocyte recovery after autologous stem cell transplantation in patients with lymphoproliferative disorders (abstract). Blood 100[Suppl]:5496
25. Kim H, Sohn HJ, Kim SE, Kang HJ, Park S, Kim S, Kim WK, Lee JW, Suh C (2004) Lymphocyte recovery as a positive predictor of prolonged survival after autologous peripheral blood stem cell transplantation in T-cell non-Hodgkin's lymphoma. Bone Marrow Transplant 34:43-49
26. Ferrandina G, Pierelli L, Perillo A, Rutella S, Ludovisi M, Leone G, Mancuso S, Scambia G (2003) Lymphocyte recovery in advanced ovarian cancer patients after high-dose chemotherapy and peripheral blood stem cell plus growth factor support: clinical implications. Clin Cancer Res 9:195-200
27. Yoong YL, Porrata LF, Inwards DJ, Micallef IN, Ansell SM, Markovic SN (2001) Kinetics of absolute lymphocyte count recovery correlates with survival after autologous stem cell transplantation in non-Hodgkin lymphoma, multiple myeloma, acute myeloid leukemia, and breast cancer (abstract). Blood 98:691a
28. Ackerstein A, Kedar E, Slavin S (1991) Use of recombinant human interleukin-2 in conjunction with syngeneic bone marrow transplantation in mice as a model of control of minimal residual disease in malignant hematologic disorders. Blood 78:1212-1215
29. Mielcarck M, Storb R (2003) Non-myeloablative hematopoietic cell transplantation as immunotherapy for hematopoietic malignancies. Cancer Treat Rev 29:283-290
30. Bradfield SM, Radich JP, Loken MR (2004) Graft-versus-leukemia effect in acute lymphoblastic leukemia: the importance of tumor burden and early detection. Leukemia 18:1156-1158
31. Guillaume T, Rubinstein DB, Symann M (1998) Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood 92:1471-1490
32. Porrata LF, Litzow MR, Markovic SN (2001) Immune reconstitution after autologous hematopoietic stem cell transplantation. Mayo Clin Proc 76:407-412
33. Porrata LF, Inwards DJ, Lacy MQ, Markovic SN (2001) Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-α in autologous stem cell transplantation. Bone Marrow Transplant 28:673-680
34. Mackall CL, Fleisher TA, Brown MR, Magrath IT, Shad AT, Horowitz ME, Wexler LH, Adde MA, McClure LL, Gress RE (1994) Lymphocyte depletion during treatment with intensive-chemotherapy for cancer. Blood 84:2221-2228
35. Talmadge JE, Reed E, Ino K, Kessinger A, Kuszynski C, Heimann D, Varney M, Jackson J, Vose JM, Bierman PJ (1997) Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow. Bone Marrow Transplant 19:161-172
36. Kook H, Goldman F, Padley D, Giller R, Rumelhart S, Holida M, Lee N, Peters C, Comito M, Huling D, Trigg M (1996) Reconstitution of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery. Blood 88:1089-1097
37. Lotzova E, Savary CA, Champlin RE (1993) Genesis of human oncolytic natural killer cells from primitive CD34+CD33- bone marrow progenitors. J Immunol 150:5263-5269
38. Miller JS, Verfaillie C, McGlave P (1992) The generation of human natural killer cells from CD34+/DR-primitive progenitors in long-term bone marrow culture. Blood 80:2182-2187
39. Cooley S, Burns LJ, Repka T, Miller JS (1999) Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu. Exp Hematol 27:1533-1541
40. Frohn C, Hoppner M, Schlenke P, Kirchner H, Koritke P, Luhm J (2002) Anti-myeloma activity of natural killer lymphocytes. Br J Haematol 119:660-664
41. Oshimi K, Oshimi Y, Akutsu M, Takei Y, Saito H, Okada M, Mizoguchi H (1986) Cytotoxicity of interleukin-2-activated lymphocytes for leukemias and lymphoma cells. Blood 68:938-948
42. Porrata LF, Litzow MR, Gertz MA et al (2003) Early natural killer cell engraftment improves progression-free survival after autologous hematopoietic stem cell transplantation (abstract). Blood 102:3680
43. Imai K, Matsuyama S, Miyake S, Suga K, Nakachi K (2000) Natural cytotoxicity activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 256:1795-1799
44. Porrata LF, Litzow MR, Inwards DJ, Gastineau DA, Moore SB, Pineda AA, Bundy KL, Padley DJ, Persky D, Lacy MQ, Dispenzieri A, Snow DS, Markovic SN (2004) Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma. Bone Marrow Transplant 33:291-298
45. Porrata LF, Gertz MA, Geyer SM, Litzow MR, Gastineau DA, Moore SB, Pineda AA, Bundy KL, Padley DJ, Persky D, Lacy MQ, Dispenzieri A, Snow DS, Markovic SN (2004) The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma. Leukemia 18:1085-1092
46. Verbik DJ, Jackson JD, Pirruccello SJ, Patil KD, Kessinger A, Joshi SS (1995) Functional and phenotypic characterization of human peripheral blood stem cell harvests: a comparative analysis of cells from consecutive collections. Blood 85:1964-1970
47. Porrata LF, Gastineau DA, Padley D, Bundy K, Markovic SN (2003) Re-infused autologous graft natural killer cells correlates with absolute lymphocyte count recovery after autologous stem cell transplantation. Leuk Lymphoma 44:997-1000
48. Shimoni A, Korbling M (2002) Tumor cell contamination in re-infused stem cell autografts: does it have clinical significance? Crit Rev Oncol Hematol 41:241-250
49. Bierman PJ, Sweetenham JW, Loberiza FR Jr, Taghipour G, Lazarus HM, Rizzo JD, Schmitz N, van Besien K, Vose JM, Horowitz M, Goldstone A; Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation (2003) Syngeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation. J Clin Oncol 21:3744-3733
50. Schouten HC, Qian W, Kvaloy S, Porcellini A, Hagberg H, Johnson JE, Doorduijn JK, Sydes MR, Kvalheim G (2003) High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial. J Clin Oncol 21:3918-3927
51. Lauria F, Raspadori D, Ventura MA, Rondelli D, Zinzani PL, Gherlinzoni F, Miggiano MC, Fiacchini M, Rosti G, Rizzi S, Tura S (1996) Immunologic and clinical modification following low-dose subcutaneous administration of rIL-2 in non-Hodgkin's lymphoma patients after autologous bone marrow transplantation. Bone Marrow Transplant 18:79-85